GB9827882D0 - Novel compounds - Google Patents

Novel compounds

Info

Publication number
GB9827882D0
GB9827882D0 GBGB9827882.3A GB9827882A GB9827882D0 GB 9827882 D0 GB9827882 D0 GB 9827882D0 GB 9827882 A GB9827882 A GB 9827882A GB 9827882 D0 GB9827882 D0 GB 9827882D0
Authority
GB
United Kingdom
Prior art keywords
novel compounds
novel
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB9827882.3A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
Original Assignee
SmithKline Beecham Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Ltd filed Critical SmithKline Beecham Ltd
Priority to GBGB9827882.3A priority Critical patent/GB9827882D0/en
Publication of GB9827882D0 publication Critical patent/GB9827882D0/en
Priority to CZ20012151A priority patent/CZ20012151A3/cs
Priority to CA002355234A priority patent/CA2355234A1/fr
Priority to EP99964526A priority patent/EP1140946A2/fr
Priority to CN99816080A priority patent/CN1335850A/zh
Priority to JP2000588178A priority patent/JP2002532501A/ja
Priority to KR1020017007626A priority patent/KR20010108028A/ko
Priority to BR9916307-1A priority patent/BR9916307A/pt
Priority to PL99353156A priority patent/PL353156A1/xx
Priority to IL14378299A priority patent/IL143782A0/xx
Priority to PCT/EP1999/009564 priority patent/WO2000035919A2/fr
Priority to AU30360/00A priority patent/AU3036000A/en
Priority to HU0104662A priority patent/HUP0104662A2/hu
Priority to TR2001/01764T priority patent/TR200101764T2/xx
Priority to CO99078949A priority patent/CO5150146A1/es
Priority to NO20013003A priority patent/NO20013003L/no
Priority to HK02101212.8A priority patent/HK1041480A1/zh
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/22—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed systems contains four or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Anesthesiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
GBGB9827882.3A 1998-12-17 1998-12-17 Novel compounds Ceased GB9827882D0 (en)

Priority Applications (17)

Application Number Priority Date Filing Date Title
GBGB9827882.3A GB9827882D0 (en) 1998-12-17 1998-12-17 Novel compounds
TR2001/01764T TR200101764T2 (tr) 1998-12-17 1999-12-03 Yeni bileşikler.
PL99353156A PL353156A1 (en) 1998-12-17 1999-12-03 Compounds
PCT/EP1999/009564 WO2000035919A2 (fr) 1998-12-17 1999-12-03 Composes
EP99964526A EP1140946A2 (fr) 1998-12-17 1999-12-03 Composes
CN99816080A CN1335850A (zh) 1998-12-17 1999-12-03 化合物
JP2000588178A JP2002532501A (ja) 1998-12-17 1999-12-03 キノリン誘導体
KR1020017007626A KR20010108028A (ko) 1998-12-17 1999-12-03 퀴놀린 유도체
BR9916307-1A BR9916307A (pt) 1998-12-17 1999-12-03 Derivados quinolina
CZ20012151A CZ20012151A3 (cs) 1998-12-17 1999-12-03 Chinolinové deriváty
IL14378299A IL143782A0 (en) 1998-12-17 1999-12-03 Quinoline derivatives
CA002355234A CA2355234A1 (fr) 1998-12-17 1999-12-03 Composes
AU30360/00A AU3036000A (en) 1998-12-17 1999-12-03 Compounds
HU0104662A HUP0104662A2 (hu) 1998-12-17 1999-12-03 Kombinált 5HT1A, 5HT1B és 5HT1D receptor antagonista aktivitással rendelkező kinolinszármazékok, eljárás az előállításukra és a vegyületeket tartalmazó gyógyszerkészítmények
CO99078949A CO5150146A1 (es) 1998-12-17 1999-12-17 Nuevos compuestos y su proceso de preparacion
NO20013003A NO20013003L (no) 1998-12-17 2001-06-15 Kinolin-derivater
HK02101212.8A HK1041480A1 (zh) 1998-12-17 2002-02-19 喹啉衍生物

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9827882.3A GB9827882D0 (en) 1998-12-17 1998-12-17 Novel compounds

Publications (1)

Publication Number Publication Date
GB9827882D0 true GB9827882D0 (en) 1999-02-10

Family

ID=10844468

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9827882.3A Ceased GB9827882D0 (en) 1998-12-17 1998-12-17 Novel compounds

Country Status (17)

Country Link
EP (1) EP1140946A2 (fr)
JP (1) JP2002532501A (fr)
KR (1) KR20010108028A (fr)
CN (1) CN1335850A (fr)
AU (1) AU3036000A (fr)
BR (1) BR9916307A (fr)
CA (1) CA2355234A1 (fr)
CO (1) CO5150146A1 (fr)
CZ (1) CZ20012151A3 (fr)
GB (1) GB9827882D0 (fr)
HK (1) HK1041480A1 (fr)
HU (1) HUP0104662A2 (fr)
IL (1) IL143782A0 (fr)
NO (1) NO20013003L (fr)
PL (1) PL353156A1 (fr)
TR (1) TR200101764T2 (fr)
WO (1) WO2000035919A2 (fr)

Families Citing this family (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9926303D0 (en) * 1999-11-05 2000-01-12 Smithkline Beecham Plc Novel compounds
EP1844771A3 (fr) * 2001-06-20 2007-11-07 Wyeth Dérives d'acide indole substitue utilises en tant qu'inhibiteurs de l'inhibiteur-1 (PAI-1) de l'activateur plasminogene
ATE367812T1 (de) 2001-06-20 2007-08-15 Wyeth Corp Substituierte indolsäurederivate als inhibitoren von plasminogen-aktivator-inhibitor-1 (pai-1)
TWI224101B (en) 2001-06-20 2004-11-21 Wyeth Corp Substituted naphthyl indole derivatives as inhibitors of plasminogen activator inhibitor type-1 (PAI-1)
US7084156B2 (en) 2001-11-27 2006-08-01 Merck & Co., Inc. 2-Aminoquinoline compounds
JP2006510673A (ja) 2002-12-10 2006-03-30 ワイス プラスミノゲンアクティベータインヒビター１（ｐａｉ−１）のインヒビターとしての、アリール、アリールオキシ、および、アルキルオキシ置換１ｈ−インドール−３−イルグリオキシル酸誘導体
CN1726191A (zh) 2002-12-10 2006-01-25 惠氏公司 用作纤溶酶原激活物抑制剂－1(pai－1)的抑制剂的取代的吲哚氧代－乙酰氨基乙酸衍生物
WO2004052855A2 (fr) 2002-12-10 2004-06-24 Wyeth Derives substitues d'acides 3-carbonyl-1h-indol-1-yl acetique comme inhibiteurs de l'ihibiteur-1 d'activation plasminogenique
UA80453C2 (en) 2002-12-10 2007-09-25 Derivatives of substituted dyhydropyranoindol-3,4-dion as inhibitors of plasminogen activator inhibitor-1 (pai-1)
ES2268480T3 (es) 2002-12-10 2007-03-16 Wyeth Derivados del acido 3-alquilo- y 3-arilalquilo-1h-indol-1-il-acetico sustituidos como inhibidores del inhibidor del activador del plasminogeno-1 (pai-1).
US7332521B2 (en) 2003-09-25 2008-02-19 Wyeth Substituted indoles
US7442805B2 (en) 2003-09-25 2008-10-28 Wyeth Substituted sulfonamide-indoles
US7351726B2 (en) 2003-09-25 2008-04-01 Wyeth Substituted oxadiazolidinediones
US7265148B2 (en) 2003-09-25 2007-09-04 Wyeth Substituted pyrrole-indoles
US7141592B2 (en) 2003-09-25 2006-11-28 Wyeth Substituted oxadiazolidinediones
US7446201B2 (en) 2003-09-25 2008-11-04 Wyeth Substituted heteroaryl benzofuran acids
US7268159B2 (en) 2003-09-25 2007-09-11 Wyeth Substituted indoles
US7582773B2 (en) 2003-09-25 2009-09-01 Wyeth Substituted phenyl indoles
US7163954B2 (en) 2003-09-25 2007-01-16 Wyeth Substituted naphthyl benzothiophene acids
BRPI0418102A (pt) 2003-12-23 2007-04-27 Pfizer derivados de quinolina
UY30892A1 (es) 2007-02-07 2008-09-02 Smithkline Beckman Corp Inhibidores de la actividad akt
CN103619171B (zh) 2010-11-03 2015-11-25 陶氏益农公司 杀虫组合物和与其相关的方法
CN104010505B (zh) 2011-10-26 2017-03-15 陶氏益农公司 杀虫组合物和与其相关的方法
NZ700595A (en) 2012-04-27 2016-04-29 Dow Agrosciences Llc Pesticidal compositions and processes related thereto
US9282739B2 (en) 2012-04-27 2016-03-15 Dow Agrosciences Llc Pesticidal compositions and processes related thereto
US9708288B2 (en) 2012-04-27 2017-07-18 Dow Agrosciences Llc Pesticidal compositions and processes related thereto
US10092574B2 (en) 2012-09-26 2018-10-09 Valorisation-Recherche, Limited Partnership Inhibitors of polynucleotide repeat-associated RNA foci and uses thereof
MX2016004940A (es) 2013-10-17 2016-06-28 Dow Agrosciences Llc Proceso para la preparacion de compuestos plaguicidas.
CN105636440A (zh) 2013-10-17 2016-06-01 美国陶氏益农公司 制备杀虫化合物的方法
CA2925914A1 (fr) 2013-10-17 2015-04-23 Dow Agrosciences Llc Procedes de preparation de composes pesticides
MX2016004945A (es) 2013-10-17 2016-06-28 Dow Agrosciences Llc Procesos para la preparacion de compuestos plaguicidas.
KR20160074540A (ko) 2013-10-17 2016-06-28 다우 아그로사이언시즈 엘엘씨 살충성 화합물의 제조 방법
JP2016539092A (ja) 2013-10-17 2016-12-15 ダウ アグロサイエンシィズ エルエルシー 有害生物防除性化合物の製造方法
CN105636446B (zh) 2013-10-17 2018-07-13 美国陶氏益农公司 制备杀虫化合物的方法
CA2926438A1 (fr) 2013-10-22 2015-04-30 Dow Agrosciences Llc Compositions pesticides et procedes associes
CA2927206A1 (fr) 2013-10-22 2015-04-30 Dow Agrosciences Llc Compositions pesticides synergiques et procedes associes
RU2656391C2 (ru) 2013-10-22 2018-06-05 ДАУ АГРОСАЙЕНСИЗ ЭлЭлСи Пестицидные композиции и связанные с ними способы
NZ719759A (en) 2013-10-22 2017-05-26 Dow Agrosciences Llc Pesticidal compositions and related methods
RU2658995C2 (ru) 2013-10-22 2018-06-26 ДАУ АГРОСАЙЕНСИЗ ЭлЭлСи Пестицидные композиции и связанные с ними способы
RU2016119560A (ru) 2013-10-22 2017-11-28 ДАУ АГРОСАЙЕНСИЗ ЭлЭлСи Синергетические пестицидные композиции и относящиеся к ним способы
RU2016119553A (ru) 2013-10-22 2017-12-04 ДАУ АГРОСАЙЕНСИЗ ЭлЭлСи Синергетические пестицидные композиции и связанные с ними способы
EP3060045A4 (fr) 2013-10-22 2017-04-05 Dow AgroSciences LLC Compositions pesticides synergiques et procédés associés
US9788545B2 (en) 2013-10-22 2017-10-17 Dow Agrosciences Llc Synergistic pesticidal compositions and related methods
CN108812681B (zh) 2013-10-22 2021-02-26 美国陶氏益农公司 杀虫组合物和与其相关的方法
AR098090A1 (es) 2013-10-22 2016-05-04 Dow Agrosciences Llc Composiciones plaguicidas sinérgicas y métodos relacionados
TW201519777A (zh) 2013-10-22 2015-06-01 Dow Agrosciences Llc 協同性殺蟲組成物及相關方法（九）
WO2015061155A1 (fr) 2013-10-22 2015-04-30 Dow Agrosciences Llc Compositions pesticides et procédés associés
EP3060051A4 (fr) 2013-10-22 2017-04-05 Dow AgroSciences LLC Compositions pesticides synergiques et méthodes associées
US9155304B2 (en) 2013-10-22 2015-10-13 Dow Agrosciences Llc Synergistic pesticidal compositions and related methods
TW201519776A (zh) 2013-10-22 2015-06-01 Dow Agrosciences Llc 協同性殺蟲組成物及相關方法（八）
RU2016119360A (ru) 2013-10-22 2017-11-28 ДАУ АГРОСАЙЕНСИЗ ЭлЭлСи Синергетические пестицидные композиции и связанные с ними способы
US9249122B1 (en) 2014-07-31 2016-02-02 Dow Agrosciences Llc Process for the preparation of 3-(3-chloro-1H-pyrazol-1-yl)pyridine
EP3174856A4 (fr) 2014-07-31 2018-01-10 Dow AgroSciences LLC Procédé pour la préparation de 3-(3-chloro-1h-pyrazol-1-yl) pyridine
EP3186229A4 (fr) 2014-07-31 2018-01-10 Dow AgroSciences LLC Procédé pour la préparation de 3-(3-méthyl-phényl-1h-pyrazol-1-yl)pyridine
BR112017002735A2 (pt) 2014-08-19 2017-12-19 Dow Agrosciences Llc processo para a preparação de 3-(3-cloro-1h-pirazol-1-il)piridina
CA2960985A1 (fr) 2014-09-12 2016-03-17 Dow Agrosciences Llc Procede de preparation de 3-(3-chloro-1h-pyrazol-1-yl)pyridine
US10233155B2 (en) 2016-12-29 2019-03-19 Dow Agrosciences Llc Processes for the preparation of pesticide compounds
CN110139853B (zh) 2016-12-29 2023-06-16 美国陶氏益农公司 用于制备杀有害生物化合物的方法
CN108570450A (zh) * 2017-03-11 2018-09-25 华中科技大学鄂州工业技术研究院 一种细胞模型及其构建和筛选五羟色胺受体靶点活性物质之应用
CN106883192B (zh) * 2017-03-30 2019-05-14 苏州汉德创宏生化科技有限公司 含氮类杂环抗肿瘤药物活性物恶唑基修饰的苯甲酸类化合物的合成方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995006644A1 (fr) * 1993-09-03 1995-03-09 Smithkline Beecham Plc Derives d'amide en tant qu'antagonistes du recepteur de 5ht1d
IL132409A0 (en) * 1997-04-18 2001-03-19 Smithkline Beecham Plc Indole derivatives having combined 5ht1a 5ht1b and 5ht1d receptor antagonist activity
WO1998047868A1 (fr) * 1997-04-18 1998-10-29 Smithkline Beecham Plc Derives d'uree contenant un heterocycle utilises comme antagonistes des recepteurs 5ht1a, 5ht1b et 5ht¿1d?
JP2002508366A (ja) * 1997-12-12 2002-03-19 スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー キノリンピペラジンおよびキノリンピペリジン誘導体、それらの製造方法、ならびに複合的５−ｈｔ１ａ、５−ｈｔ１ｂおよび５−ｈｔ１ｄ受容体アンタゴニストとしてのそれらの用途

Also Published As

Publication number Publication date
PL353156A1 (en) 2003-10-20
CN1335850A (zh) 2002-02-13
CO5150146A1 (es) 2002-04-29
IL143782A0 (en) 2002-04-21
HUP0104662A2 (hu) 2002-04-29
NO20013003D0 (no) 2001-06-15
HK1041480A1 (zh) 2002-07-12
TR200101764T2 (tr) 2001-10-22
CZ20012151A3 (cs) 2001-12-12
EP1140946A2 (fr) 2001-10-10
WO2000035919A2 (fr) 2000-06-22
KR20010108028A (ko) 2001-12-07
NO20013003L (no) 2001-07-25
BR9916307A (pt) 2002-01-15
AU3036000A (en) 2000-07-03
JP2002532501A (ja) 2002-10-02
CA2355234A1 (fr) 2000-06-22
WO2000035919A3 (fr) 2000-10-26

Similar Documents

Publication Publication Date Title
GB9827882D0 (en) Novel compounds
GB9803411D0 (en) Novel compounds
GB9801392D0 (en) Novel compounds
GB9803194D0 (en) Novel compounds
GB9802656D0 (en) Novel compounds
GB9801635D0 (en) Novel compounds
GB9801643D0 (en) Novel compounds
GB9802387D0 (en) Novel compounds
GB9802533D0 (en) Novel compounds
GB9803306D0 (en) Novel compounds
GB9801630D0 (en) Novel compounds
GB9800337D0 (en) Novel compounds
GB9800324D0 (en) Novel compounds
GB9800317D0 (en) Novel compounds
GB9800289D0 (en) Novel compounds
GB9802639D0 (en) Novel compounds
GB9802640D0 (en) Novel compounds
GB9802644D0 (en) Novel compounds
GB9802645D0 (en) Novel compounds
GB9802646D0 (en) Novel compounds
GB9817319D0 (en) Novel compounds
GB9803428D0 (en) Novel compounds
GB9801632D0 (en) Novel compounds
GB9802653D0 (en) Novel compounds
GB9803290D0 (en) Novel compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)